Dr. Reddy's to Release Q3 FY13 Results on February 14, 2013

  Dr. Reddy's to Release Q3 FY13 Results on February 14, 2013

       Earnings Call Slated for February 14, 6.30 PM IST / 8.00 AM EST*

Business Wire

HYDERABAD, India -- February 6, 2013

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third
Quarter and Nine months ended December 31, 2012 on Thursday, February 14, 2013
after the Board Meeting. The results will be available on the Company’s
website www.drreddys.com.

Summary of Events
Event                  Date and Time (IST)          Medium
Release of financial   February 14th, after the     Email, Media, Company
results                Board Meeting                website, Business Wire
                       February 14th, 6.30 PM IST   Hosted by the Company
Earnings Call          / 8.00 AM EST
                                                    (Details below)
                       February 14th, 6.30 PM IST   URL available on Company’s
Webcast of Earnings    / 8.00 AM EST through        website,
Call                   February 19th, 2013
Transcripts of the     Will be available on the     URL available on Company’s
Earnings call          Company’s website            website, www.drreddys.com

Earnings Call

Following the release, the management of the Company will host an earnings
call to discuss the Company’s financial performance.

Conference Dial-In Numbers
Primary Number:              +91 22 3065 0136
Secondary Number:            +91 22 6629 0356
The numbers listed above are universally accessible from all networks and all
                              6000 1221
                              Available in - Ahmedabad, Bangalore, Chennai,
                              Cochin, Delhi (NCR), Hyderabad, Kolkata, Lucknow
Local Access Number:          Accessible from all major carriers except
                              3940 3977
                              Available in Ahmedabad, Bangalore, Chandigarh,
                              Chennai, Cochin, Gurgaon (NCR), Hyderabad,
                              Kolkata, Lucknow, Pune
                            Accessible from all carriers.
                              USA: 1 866 746 2133
International Toll Free       UK: 0 808 101 1573
                              Singapore: 800 101 2045
                            Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the other calls. As
participation in the call is limited, early registration is encouraged. The
operator will provide instructions on asking questions before and during the

Audio Webcast

The audio webcast of the earnings call will be available to all interested
parties at www.drreddys.com. Please visit the web site at least fifteen
minutes ahead of the scheduled start time to register and to download and
install any necessary audio software. Participants in the webcast can listen
to the proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through Feb 19th, 2013. For play
back dial in phone No: 022 3065 1212 and ID: 375#.


The transcript of the earnings call will also be available on the Company's

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global
pharmaceutical company, committed to providing affordable and innovative
medicines for healthier lives. Through its three businesses - Pharmaceutical
Services and Active Ingredients, Global Generics and Proprietary Products –
Dr. Reddy’s offers a portfolio of products and services including APIs, custom
pharmaceutical services, generics, biosimilars, differentiated formulations
and NCEs. Therapeutic focus is on gastro-intestinal, cardiovascular,
diabetology, oncology, pain management, anti-infective and pediatrics. Major
markets include India, USA, Russia and CIS, Germany, UK, Venezuela, S. Africa,
Romania, and New Zealand. For more information, log on to: www.drreddys.com.

*EST- Eastern Standard Time


Dr. Reddy’s Laboratories Ltd.
Investor Relations:
Kedar Upadhye, +91 40 66834297
Saunak Savla, +91 40 49002135
Milan Kalawadia (USA), +1 9082034931
Press spacebar to pause and continue. Press esc to stop.